Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ola Landgren

Showing results (211-220 of 519) with videos related to

Pageof 52
Sort By:
Cytometry. Part B, Clinical Cytometry|September 15, 2010
Different biology and clinical outcome according to the absolute numbers of clonal B-cells in monoclonal B-cell lymphocytosis (MBL)Andy C Rawstron, Tait Shanafelt, Mark C Lanasa, et al.
International Journal of Cancer|June 23, 2007
Ascertainment and diagnostic accuracy for hematopoietic lymphoproliferative malignancies in Sweden 1964-2003Ingemar Turesson, Martha S Linet, Magnus Björkholm, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|April 25, 2020
Critical Appraisal of Published Indirect Comparisons and Network Meta-Analyses of Competing Interventions for Multiple MyelomaShannon Cope, Kabirraaj Toor, Evan Popoff, et al.
American Journal of Hematology|May 6, 2011
Patterns of monoclonal immunoglobulins and serum free light chains are significantly different in black compared to white monoclonal gammopathy of undetermined significance (MGUS) patientsBrendan M Weiss, Alex Minter, Jude Abadie, et al.
European Journal of Haematology|October 29, 2021
Survival, causes of death, and the prognostic role of comorbidities in chronic lymphocytic leukemia in the pre-ibrutinib era: A population-based studyVilhjálmur Steingrímsson, Sigrún H Lund, Paul W Dickman, et al.
American Journal of Hematology|October 25, 2011
Circulating cytokine levels, Epstein-Barr viremia, and risk of acquired immunodeficiency syndrome-related non-Hodgkin lymphomaCharles S Rabkin, Eric A Engels, Ola Landgren, et al.
British Journal of Haematology|March 26, 2019
Parental longevity and survival among patients with multiple myeloma and monoclonal gammopathy of undetermined significance: a population-based studyIngigerður S Sverrisdóttir, Sigrún H Lund, Ingemar Turesson, et al.
The Journal of Molecular Diagnostics : JMD|April 18, 2020
Mass Spectrometry-Based Method Targeting Ig Variable Regions for Assessment of Minimal Residual Disease in Multiple MyelomaCarlo O Martins, Sarah Huet, San S Yi, et al.
Blood|November 4, 2006
Respiratory tract infections and subsequent risk of chronic lymphocytic leukemiaOla Landgren, Joshua S Rapkin, Neil E Caporaso, et al.
Blood|July 29, 2011
Risk of acute myeloid leukemia and myelodysplastic syndromes after multiple myeloma and its precursor disease (MGUS)Sham Mailankody, Ruth M Pfeiffer, Sigurdur Y Kristinsson, et al.
Pageof 52

Showing results (211-220 of 519) with videos related to

Sort By:
Pageof 52
Cytometry. Part B, Clinical Cytometry|September 15, 2010
Different biology and clinical outcome according to the absolute numbers of clonal B-cells in monoclonal B-cell lymphocytosis (MBL)Andy C Rawstron, Tait Shanafelt, Mark C Lanasa, et al.
International Journal of Cancer|June 23, 2007
Ascertainment and diagnostic accuracy for hematopoietic lymphoproliferative malignancies in Sweden 1964-2003Ingemar Turesson, Martha S Linet, Magnus Björkholm, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|April 25, 2020
Critical Appraisal of Published Indirect Comparisons and Network Meta-Analyses of Competing Interventions for Multiple MyelomaShannon Cope, Kabirraaj Toor, Evan Popoff, et al.
American Journal of Hematology|May 6, 2011
Patterns of monoclonal immunoglobulins and serum free light chains are significantly different in black compared to white monoclonal gammopathy of undetermined significance (MGUS) patientsBrendan M Weiss, Alex Minter, Jude Abadie, et al.
European Journal of Haematology|October 29, 2021
Survival, causes of death, and the prognostic role of comorbidities in chronic lymphocytic leukemia in the pre-ibrutinib era: A population-based studyVilhjálmur Steingrímsson, Sigrún H Lund, Paul W Dickman, et al.
American Journal of Hematology|October 25, 2011
Circulating cytokine levels, Epstein-Barr viremia, and risk of acquired immunodeficiency syndrome-related non-Hodgkin lymphomaCharles S Rabkin, Eric A Engels, Ola Landgren, et al.
British Journal of Haematology|March 26, 2019
Parental longevity and survival among patients with multiple myeloma and monoclonal gammopathy of undetermined significance: a population-based studyIngigerður S Sverrisdóttir, Sigrún H Lund, Ingemar Turesson, et al.
The Journal of Molecular Diagnostics : JMD|April 18, 2020
Mass Spectrometry-Based Method Targeting Ig Variable Regions for Assessment of Minimal Residual Disease in Multiple MyelomaCarlo O Martins, Sarah Huet, San S Yi, et al.
Blood|November 4, 2006
Respiratory tract infections and subsequent risk of chronic lymphocytic leukemiaOla Landgren, Joshua S Rapkin, Neil E Caporaso, et al.
Blood|July 29, 2011
Risk of acute myeloid leukemia and myelodysplastic syndromes after multiple myeloma and its precursor disease (MGUS)Sham Mailankody, Ruth M Pfeiffer, Sigurdur Y Kristinsson, et al.
Pageof 52